These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29309655)

  • 1. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants.
    ; Harris T; Sandford R; ;
    Nephrol Dial Transplant; 2018 Apr; 33(4):563-573. PubMed ID: 29309655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.
    Tong A; Tunnicliffe DJ; Lopez-Vargas P; Mallett A; Patel C; Savige J; Campbell K; Patel M; Tchan MC; Alexander SI; Lee V; Craig JC; Fassett R; Rangan GK
    Nephrology (Carlton); 2016 Feb; 21(2):122-32. PubMed ID: 26235729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Building a network of ADPKD reference centres across Europe: the EuroCYST initiative.
    Petzold K; Gansevoort RT; Ong AC; Devuyst O; Rotar L; Eckardt KU; Köttgen A; Pirson Y; Remuzzi G; Sandford R; Tesar V; Ecder T; Chaveau D; Torra R; Budde K; Le Meur Y; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv26-32. PubMed ID: 25165183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and study protocol of ACQUIRE, a prospective, observational study measuring quality of life, treatment preference and treatment satisfaction of autosomal dominant polycystic kidney disease (ADPKD) patients in Europe.
    Joly D; Quinn J; Mokiou S; O'Reilly K; Sánchez-Covisa J; Wang-Silvanto J; Doll H
    BMC Nephrol; 2020 Jul; 21(1):298. PubMed ID: 32709218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
    Cho Y; Sautenet B; Rangan G; Craig JC; Ong ACM; Chapman A; Ahn C; Chen D; Coolican H; Kao JT; Gansevoort R; Perrone R; Harris T; Torres V; Pei Y; Kerr PG; Ryan J; Gutman T; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Hamiwka LA; Tong A
    Trials; 2017 Nov; 18(1):560. PubMed ID: 29169385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in management of autosomal-dominant polycystic kidney disease.
    Potts JW; Mousa SA
    Am J Health Syst Pharm; 2017 Dec; 74(23):1959-1968. PubMed ID: 29167138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
    Cho Y; Tong A; Craig JC; Mustafa RA; Chapman A; Perrone RD; Ahn C; Fowler K; Torres V; Gansevoort RT; Ong ACM; Coolican H; Tze-Wah Kao J; Harris T; Gutman T; Shen JI; Viecelli AK; Johnson DW; Au E; El-Damanawi R; Logeman C; Ju A; Manera KE; Chonchol M; Odland D; Baron D; Pei Y; Sautenet B; Rastogi A; Sharma A; Rangan G;
    Am J Kidney Dis; 2021 Feb; 77(2):255-263. PubMed ID: 32771648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
    Cho Y; Rangan G; Logeman C; Ryu H; Sautenet B; Perrone RD; Nadeau-Fredette AC; Mustafa RA; Htay H; Chonchol M; Harris T; Gutman T; Craig JC; Ong ACM; Chapman A; Ahn C; Coolican H; Kao JT; Gansevoort RT; Torres V; Pei Y; Johnson DW; Viecelli AK; Teixeira-Pinto A; Howell M; Ju A; Manera KE; Tong A
    Am J Kidney Dis; 2020 Sep; 76(3):361-373. PubMed ID: 32359822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.
    Harris T; Bridges HR; Brown WD; O'Brien NL; Daly AC; Jindal BK; Mundy GS; Ong A; Power AJ; Sandford RN; Sayer J; Simms RJ; Wilson PD; Winyard PJD; Tarpey M
    BMJ Open; 2022 Jun; 12(6):e055780. PubMed ID: 35705349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
    Oberdhan D; Cole JC; Krasa HB; Cheng R; Czerwiec FS; Hays RD; Chapman AB; Perrone RD
    Am J Kidney Dis; 2018 Feb; 71(2):225-235. PubMed ID: 29150246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
    Sautenet B; Cho Y; Gutman T; Rangan G; Ong A; Chapman AB; Ahn C; Coolican H; Tze-Wah Kao J; Fowler K; Gansevoort RT; Geneste C; Perrone RD; Harris T; Torres VE; Pei Y; Craig JC; Tong A;
    Am J Kidney Dis; 2020 Aug; 76(2):213-223. PubMed ID: 32171640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Management of Patients with Adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) Requires a Multidisciplinary Approach].
    Bucci R; De Rosa LI; Brambilla Pisoni M; Farinone S; Vespa M; Joli G; Catania M; Kola K; Tunesi F; Brioni E; Carrera P; Mancassola G; Citterio L; Manunta P; Vezzoli G; Sciarrone Alibrandi MT
    G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ESRD in patients with autosomal dominant polycystic kidney disease.
    Alam A; Perrone RD
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):164-72. PubMed ID: 20219619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
    Simms RJ; Thong KM; Dworschak GC; Ong AC
    Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.
    Luciano RL; Dahl NK
    Nephrol Dial Transplant; 2014 Feb; 29(2):247-54. PubMed ID: 24215018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.
    Spithoven EM; Kramer A; Meijer E; Orskov B; Wanner C; Caskey F; Collart F; Finne P; Fogarty DG; Groothoff JW; Hoitsma A; Nogier MB; Postorino M; Ravani P; Zurriaga O; Jager KJ; Gansevoort RT; ; ; ; ;
    Kidney Int; 2014 Dec; 86(6):1244-52. PubMed ID: 24827775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
    Logeman C; Cho Y; Sautenet B; Rangan GK; Gutman T; Craig J; Ong A; Chapman A; Ahn C; Coolican H; Tze-Wah Kao J; Gansevoort RT; Perrone R; Harris T; Torres V; Fowler K; Pei Y; Kerr P; Ryan J; Johnson D; Viecelli A; Geneste C; Kim H; Kim Y; Howell M; Ju A; Manera KE; Teixeira-Pinto A; Parasivam G; Tong A
    BMJ Open; 2020 Oct; 10(10):e038005. PubMed ID: 33040007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
    Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS
    Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.